Accrol Group Holdings plc (LON:ACRL), the UK’s leading independent tissue converter, has announced that it will release its Half Year Results for the six months ended 31 October 2022, alongside the outcomes of the Strategic Review, on Tuesday, 24 January 2023.
An analyst briefing will be held online at 9.00 am on that day. Equity analysts interested in joining the meeting should contact Belvedere Communications.
As part of the Group’s Results roadshow, the management will host an online investor presentation and Q&A session. This will take place on Friday, 27 January at 12.30pm. Anyone wishing to participate should register for the event with PI World at: https://bit.ly/ACRL_H123_results_webinar.